Santa Cruz Biotechnology supplies a comprehensive collection of GSDML Antibodies for research applications. GSDML Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GSDML, or Gasdermin-L, is a key regulator of cell death and inflammation. GSDML functions by forming pores in cellular membranes, leading to pyroptosis, a form of programmed cell death associated with inflammatory responses. Understanding GSDML's molecular mechanisms provides insights into disease pathways and potential therapeutic interventions. Researchers worldwide utilize GSDML monoclonal antibodies to investigate cellular processes and disease mechanisms. Advanced research with GSDML monoclonal antibodies continues to reveal new aspects of inflammatory responses and cell death pathways. GSDML research using Santa Cruz Biotechnology monoclonal antibodies contributes significantly to advancing scientific knowledge in cell biology and disease research.